At UCLA, women with ovarian cancer are provided comprehensive care through the the Gynecologic Oncology Service, a part of the Division of Obstetrics & Gynecology at UCLA Health System.
The service manages the varied treatments for gynecologic cancers, including chemotherapy, immunotherapy and radiation treatments. Surgeries, including staging operations, cytoreductive surgery, second-look surgery and reconstructive surgery of the vagina and vulva are provided through the service as well.
Special programs, including intraperitoneal therapies and new drug therapies, may also be available through the Gynecologic Oncology Service and/or through the National Cancer Institute.
These clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
If you are interested in finding out more about these studies, visit our Clinical Trials Guide for general information and a listing of currently open clinical trials.
For more information on ovarian cancer treatment services at UCLA, visit the following related websites: